Connection

JUNYA FUJIMOTO to Tumor Suppressor Proteins

This is a "connection" page, showing publications JUNYA FUJIMOTO has written about Tumor Suppressor Proteins.
Connection Strength

0.236
  1. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1. Pathol Res Pract. 2020 Dec; 216(12):153267.
    View in: PubMed
    Score: 0.108
  2. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett. 2000 Feb 28; 149(1-2):125-34.
    View in: PubMed
    Score: 0.026
  3. Expression of p27Kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma. Oncol Rep. 1999 Sep-Oct; 6(5):983-7.
    View in: PubMed
    Score: 0.025
  4. Expression of cell-cycle-regulating transcription factor E2F-1 in colorectal carcinomas. Pathobiology. 1999 Jul-Aug; 67(4):174-9.
    View in: PubMed
    Score: 0.025
  5. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer Discov. 2018 12; 8(12):1548-1565.
    View in: PubMed
    Score: 0.023
  6. Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer. J Clin Oncol. 2018 08 10; 36(23):2386-2394.
    View in: PubMed
    Score: 0.023
  7. Alterations of p73 preferentially occur in gastric adenocarcinomas with foveolar epithelial phenotype. Int J Cancer. 1999 Oct 08; 83(2):192-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.